Cambio - Excellence in Molecular Biology

Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen's products are hazardous and may be subject to additional shipping charges. Full product information is available on Glen Research's website.

5-Me-C-scpBNA™-CE Phosphoramidite

Spirocyclopropylene bridged nucleic acid (scpBNATM) is a tricyclic analog of locked nucleic acid (LNA). scpBNA exhibits high binding affinity as well as excellent metabolic stability, ?

Glen Research

Catalogue No.DescriptionPack SizePriceQty
10-2211-02 5-Me-C-scpBNA™-CE Phosphoramidite0.25g £313.00 Quantity Add to Order
10-2211-905-Me-C-scpBNA™-CE Phosphoramidite100 umol £125.00 Quantity Add to Order

Description

Description

5'-Dimethoxytrityl-N-benzoyl-5-methyl-(2'-O, 4'-C spirocyclopropylene)- Cytidine,3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite

 

Spirocyclopropylene bridged nucleic acid (scpBNATM) is a tricyclic analog of locked nucleic acid (LNA). scpBNA exhibits high binding affinity as well as excellent metabolic stability, and these properties make scpBNA an excellent sugar modification for therapeutic applications.

Details

Usage

  • Coupling: 3 minute coupling time recommended. Increase oxidation time 3 fold for optimal performance.
  • Deprotection: No changes needed from standard method recommended by synthesizer manufacturer. Note: Deprotection in AMA (50:50 Ammonium hydroxide/MethylAmine) may result in a 4-5% 5-methyl-N4-methyl-C side product at the modification site.
Specifications
Diluent DCM:Acetonitrile (1:1)
Storage Freezer storage, -10 to -30°C, dry
Stability 1-2 Days

Intellectual Property

scpBNA™ is a trademark owned by Luxna Biotech Co., Ltd. (Luxna).

scpBNA™ phosphoramidites (Products) are protected by WO2015/125783A1, WO2020/204022A1 and their foreign patents/applications controlled by Luxna. 

Glen Research sells the Products under contract with Summit Pharmaceuticals International Corporation, which has the license from Luxna. The resale of the Products is prohibited. The Products can be used only for experimental or research use, and the uses of the Products, including processed products thereof, for any purposes other than experimental or research use is prohibited. The purchase of the Products does not grant any right for the Patents, except for experimental or research use. For any other use, the customer must obtain a license from Luxna (sales@luxnabiotech.co.jp, 81-6-6170-1228).

Dilution/Coupling Data

The table below show pack size data and, for solutions, dilution and approximate coupling based on normal priming procedures.

ABI 392/394

 

Technical Documents

Safety Data Sheet (EU)

Safety Data Sheet (Other)

Glen Report 36-21: Spirocyclopropylene bridged nucleic acid (scpBNA™) Phosphoramidites

Glen Report 36-22: New Products Spirocyclopropylene Bridged Nucleic Acids

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200